Seeking Alpha
16 Dec 2025, 21:29 UTC · 48w ago
Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript
Impact · against what's priced in
Vivos Therapeutics is facing increased risk and uncertainty as it pivots its business model and product delivery strategy. This strategic shift suggests the previous operational framework failed to gain traction, introducing significant execution risk.
- VVOS−0.45
No priced-in read yet





